1. Home
  2. NXL vs RVSN Comparison

NXL vs RVSN Comparison

Compare NXL & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • RVSN
  • Stock Information
  • Founded
  • NXL 2010
  • RVSN 2016
  • Country
  • NXL United States
  • RVSN Israel
  • Employees
  • NXL N/A
  • RVSN N/A
  • Industry
  • NXL Medical Specialities
  • RVSN
  • Sector
  • NXL Health Care
  • RVSN
  • Exchange
  • NXL Nasdaq
  • RVSN Nasdaq
  • Market Cap
  • NXL 10.0M
  • RVSN 9.4M
  • IPO Year
  • NXL 2022
  • RVSN 2022
  • Fundamental
  • Price
  • NXL $3.16
  • RVSN $1.09
  • Analyst Decision
  • NXL Hold
  • RVSN
  • Analyst Count
  • NXL 1
  • RVSN 0
  • Target Price
  • NXL N/A
  • RVSN N/A
  • AVG Volume (30 Days)
  • NXL 445.0K
  • RVSN 18.2M
  • Earning Date
  • NXL 11-08-2024
  • RVSN 02-03-2025
  • Dividend Yield
  • NXL N/A
  • RVSN N/A
  • EPS Growth
  • NXL N/A
  • RVSN N/A
  • EPS
  • NXL N/A
  • RVSN N/A
  • Revenue
  • NXL $162,078.00
  • RVSN $903,000.00
  • Revenue This Year
  • NXL $56.86
  • RVSN $1,344.37
  • Revenue Next Year
  • NXL $167.44
  • RVSN $1,143.30
  • P/E Ratio
  • NXL N/A
  • RVSN N/A
  • Revenue Growth
  • NXL 26.00
  • RVSN 347.03
  • 52 Week Low
  • NXL $0.25
  • RVSN $0.38
  • 52 Week High
  • NXL $4.49
  • RVSN $23.37
  • Technical
  • Relative Strength Index (RSI)
  • NXL 51.05
  • RVSN 48.11
  • Support Level
  • NXL $2.55
  • RVSN $1.05
  • Resistance Level
  • NXL $3.11
  • RVSN $1.77
  • Average True Range (ATR)
  • NXL 0.32
  • RVSN 0.47
  • MACD
  • NXL 0.03
  • RVSN -0.09
  • Stochastic Oscillator
  • NXL 70.71
  • RVSN 11.36

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About RVSN Rail Vision Ltd.

Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.

Share on Social Networks: